Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)
The mpox 2022 outbreak was declared a public health emergency in July 2022. In August 2022, the MVA–BN vaccine received emergency use authorization in the United States (US) to target at-risk groups. This study (EUPAS104386) used HealthVerity’s administrative US healthcare data to generate real-worl...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2024-06-01
|
| Серія: | Vaccines |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/2076-393X/12/6/651 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|